Acute liver failure

Current Opinion in Organ Transplantation

Volumn 16, Issue 3, 2011, Pages 289-296

  Nguyen, N Thao T ^a   Vierling, John M ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

acetaminophen; acute liver failure; biomarker; cause; drugs; epidemiology; herbals; keratin; liver transplantation prognosis; liver transplantation therapy

Indexed keywords

ACETYLCYSTEINE; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; ANTIMETABOLITE; BIOLOGICAL PRODUCT; ENZYME INHIBITOR; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; ORNITHINE ASPARTATE; PARACETAMOL; PLACEBO; TUBERCULOSTATIC AGENT;

ACUTE LIVER FAILURE; ALTERNATIVE MEDICINE; DEVICE THERAPY; DIET SUPPLEMENTATION; DRUG INDUCED DISEASE; DRUG MECHANISM; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GROUPS BY AGE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER SUPPORT; LIVER TOXICITY; LIVER TRANSPLANTATION; MORTALITY; NAUSEA AND VOMITING; NONHUMAN; PATHOGENESIS; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURVIVAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; EVIDENCE-BASED MEDICINE; HUMANS; INFANT; INFANT, NEWBORN; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; LIVER, ARTIFICIAL; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 79958022976     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328346c8ee     Document Type: Review

References (29)

1. Larson AM. Diagnosis and management of acute liver failure. Curr Opin Gastroenterol 2010; 26:214-221.
2. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet 2010; 376:190-201.
3. Lee WM, Squires RH Jr, Nyberg SL, et al. Acute liver failure: summary of a workshop. Hepatology 2008; 47:1401-1415. (Pubitemid 351547926)
4. Stravitz RT, Kramer DJ. Management of acute liver failure. Nat Rev Gastroenterol Hepatol 2009; 6:542-553.
5. Alam S, Azam G, Mustafa G, et al. Natural course of fulminant hepatic failure: the scenario in Bangladesh and the differences from the west. Saudi J Gastroenterol 2009; 15:229-233.
6. Lee WM, Seremba E. Etiologies of acute liver failure. Curr Opin Crit Care 2008; 14:198-201. (Pubitemid 351498786)
7. Lee WM. Etiologies of acute liver failure. Semin Liver Dis 2008; 28:142-152. (Pubitemid 351632954)
8. Gregory B, Larson AM, Reisch J, Lee WM. Acetaminophen dose does not predict outcome in acetaminophen-induced acute liver failure. J Investig Med 2010; 58:707-710.
9. Claridge LC, Eksteen B, Smith A, et al. Acute liver failure after administration of paracetamol at the maximum recommended daily dose in adults. BMJ 2010; 341:c6764.
10. Gentili A, Latrofa ME, Giuntoli L, et al. Acute liver failure associated with a prolonged course of acetaminophen at recommended dosages in paediatric age. Pediatr Med Chir 2008; 30:302-305.
11. Craig DG, Bates CM, Davidson JS, et al. Overdose pattern and outcome in paracetamol-induced acute severe hepatotoxicity. Br J Clin Pharmacol 2011; 71:273-282.
12. Khandelwal N, James LP, Sanders C, et al. Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. Hepatology 2011; 53:567-576.
13. 13Reuben A, Koch DG, Lee WM. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010; 52:2065-2076.
14. Fong TL, Klontz KC, Canas-Coto A, et al. Hepatotoxicity due to hydroxycut: A case series. Am J Gastroenterol 2010; 105:1561-1566.
15. Forde KA, Reddy KR, Troxel AB, et al. Racial and ethnic differences in presentation, etiology, and outcomes of acute liver failure in the United States. Clin Gastroenterol Hepatol 2009; 7:1121-1126.
16. Simpson KJ, Bates CM, Henderson NC, et al. The utilization of liver transplantation in the management of acute liver failure: comparison between acetaminophen and nonacetaminophen etiologies. Liver Transpl 2009; 15:600-609.
17. 17Strnad P, Zhou Q, Hanada S, et al. Keratin variants predispose to acute liver failure and adverse outcome: race and ethnic associations. Gastroenterology 2010; 139:828-835; 835.e3.
18. McPhail MJ, Wendon JA, Bernal W. Meta-analysis of performance of King's College Hospital Criteria in prediction of outcome in nonparacetamol-induced acute liver failure. J Hepatol 2010; 53:492-499.
19. Du WB, Pan XP, Li LJ. Prognostic models for acute liver failure. Hepatobiliary Pancreat Dis Int 2010; 9:122-128.
20. Yamagishi Y, Saito H, Ebinuma H, et al. A new prognostic formula for adult acute liver failure using computer tomography-derived hepatic volumetric analysis. J Gastroenterol 2009; 44:615-623.
21. Rudnick DA, Dietzen DJ, Turmelle YP, et al. Serum alpha-NH-butyric acid may predict spontaneous survival in pediatric acute liver failure. Pediatr Transplant 2009; 13:223-230.
22. Chan G, Taqi A, Marotta P, et al. Long-term outcomes of emergency liver transplantation for acute liver failure. Liver Transpl 2009; 15:1696-1702.
23. Cooper SC, Aldridge RC, Shah T, et al. Outcomes of liver transplantation for paracetamol (acetaminophen)-induced hepatic failure. Liver Transpl 2009; 15:1351-1357.
24. Mindikoglu AL, Magder LS, Regev A. Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database. Liver Transpl 2009; 15:719-729.
25. Schiodt FV, Chung RT, Schilsky ML, et al. Outcome of acute liver failure in the elderly. Liver Transpl 2009; 15:1481-1487.
26. James LP, Letzig L, Simpson PM, et al. Pharmacokinetics of acetaminophen- protein adducts in adults with acetaminophen overdose and acute liver failure. Drug Metab Dispos 2009; 37:1779-1784.
27. Lee WM, Hynan LS, Rossaro L, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage nonacetaminophen acute liver failure. Gastroenterology 2009; 137:856-864; 864.e1.
28. Acharya SK, Bhatia V, Sreenivas V, et al. Efficacy of N-acetylcysteine in acute liver failure: A double-blind, randomized, placebo-controlled study. Gastroenterology 2009; 136:2159-2168.
29. Rozga J, Malkowski P. Artificial liver support: quo vadis? Ann Transplant 2010; 15:92-101.